Table 3 Correlation between miR-657 expression and clinicopathological features in 96 NSCLC patients
Parameters | Group | N | Expression of miR-657 | P value | |
|---|---|---|---|---|---|
Low, n (%) | High, n (%) | ||||
Age (years) | ≤ 58 | 47 | 25 (53.19) | 22 (46.81) | 0.4164 |
> 58 | 49 | 22 (44.90) | 27 (55.10) | ||
Gender | Female | 48 | 23 (47.92) | 25 (52.08) | 0.6820 |
Male | 48 | 21 (43.75) | 27 (56.25) | ||
Tumor size (cm) | < 3 | 45 | 19 (42.22) | 26 (57.78) | 0.2941 |
≥ 3 | 51 | 27 (52.94) | 24 (47.06) | ||
TNM stage | I–II | 49 | 17 (34.69) | 32 (65.31) | 0.0022 |
III–IV | 47 | 31 (65.96) | 16 (34.04) | ||
Smoking history | Yes | 53 | 22 (41.51) | 31 (58.49) | 0.4728 |
No | 43 | 21 (48.84) | 22 (51.16) | ||
Lymph node metastasis | Yes | 50 | 31 (62.00) | 19 (38.00) | 0.0040 |
No | 46 | 15 (32.61) | 31 (67.39) | ||
Differentiation | Well/moderate | 49 | 14(28.57) | 35(71.43) | 0.0079 |
Poor | 47 | 26(55.32) | 21(44.68) | ||